Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

720 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity.
Dietrich S, Andrulis M, Hegenbart U, Schmitt T, Bellos F, Martens UM, Meissner J, Krämer A, Ho AD, Dreger P. Dietrich S, et al. Among authors: ho ad. Biol Blood Marrow Transplant. 2011 Aug;17(8):1250-4. doi: 10.1016/j.bbmt.2010.12.706. Epub 2011 Jan 6. Biol Blood Marrow Transplant. 2011. PMID: 21215813 Free article.
Endothelial vulnerability and endothelial damage are associated with risk of graft-versus-host disease and response to steroid treatment.
Dietrich S, Falk CS, Benner A, Karamustafa S, Hahn E, Andrulis M, Hegenbart U, Ho AD, Dreger P, Luft T. Dietrich S, et al. Among authors: ho ad. Biol Blood Marrow Transplant. 2013 Jan;19(1):22-7. doi: 10.1016/j.bbmt.2012.09.018. Epub 2012 Oct 3. Biol Blood Marrow Transplant. 2013. PMID: 23041600 Free article. Clinical Trial.
Imatinib-supplemented myeloablative total-body irradiation/cyclophosphamide conditioning prior to allogeneic stem cell transplantation as consolidation treatment in patients with blast crisis of chronic myeloid leukemia.
Radujkovic A, Dreger P, Hegenbart U, Buss EC, Luft T, Ho AD, Fruehauf S, Topaly J. Radujkovic A, et al. Among authors: ho ad. Eur J Haematol. 2014 Jun;92(6):546-9. doi: 10.1111/ejh.12289. Epub 2014 Mar 15. Eur J Haematol. 2014. PMID: 24527710 No abstract available.
Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD.
Ho AD, Schetelig J, Bochtler T, Schaich M, Schäfer-Eckart K, Hänel M, Rösler W, Einsele H, Kaufmann M, Serve H, Berdel WE, Stelljes M, Mayer J, Reichle A, Baldus CD, Schmitz N, Kramer M, Röllig C, Bornhäuser M, Thiede C, Ehninger G; Study Alliance Leukemia. Ho AD, et al. Biol Blood Marrow Transplant. 2016 Mar;22(3):462-9. doi: 10.1016/j.bbmt.2015.10.023. Epub 2015 Nov 10. Biol Blood Marrow Transplant. 2016. PMID: 26551637 Free article. Clinical Trial.
Expression of CDKN1C in the bone marrow of patients with myelodysplastic syndrome and secondary acute myeloid leukemia is associated with poor survival after conventional chemotherapy.
Radujkovic A, Dietrich S, Andrulis M, Benner A, Longerich T, Pellagatti A, Nanda K, Giese T, Germing U, Baldus S, Boultwood J, Ho AD, Dreger P, Luft T. Radujkovic A, et al. Among authors: ho ad. Int J Cancer. 2016 Sep 15;139(6):1402-13. doi: 10.1002/ijc.30181. Epub 2016 Jun 3. Int J Cancer. 2016. PMID: 27170453
The impact of allogeneic hematopoietic cell transplantation on the mortality of poor-risk non-Hodgkin lymphoma: an intent-to-transplant analysis.
Selberg L, Stadtherr P, Dietrich S, Tran TH, Luft T, Hegenbart U, Bondong A, Meissner J, Liebers N, Schmitt M, Ho AD, Müller-Tidow C, Dreger P. Selberg L, et al. Among authors: ho ad. Bone Marrow Transplant. 2021 Jan;56(1):30-37. doi: 10.1038/s41409-020-0976-4. Epub 2020 Jun 18. Bone Marrow Transplant. 2021. PMID: 32555407
720 results